About this item:

600 Views | 374 Downloads

Author Notes:

Corresponding author: Natoshia Raishevich Cunningham, Ph.D., Assistant Professor of Pediatrics, Cincinnati Children's Hospital Medical Center, Division of Behavioral Medicine and Clinical Psychology, MLC 3015, 3333 Burnet Avenue, Cincinnati, Ohio 45229-3026, telephone (513)636-2403; fax (513)636-7756, Email:natoshia.cunningham@cchmc.org

This is a pre-copy-editing, author-produced PDF of an article accepted for publication in The Journal of Rheumatology following peer review. The definitive publisher-authenticated version [insert complete citation information here] is available online at: xxxxxxx [insert URL for the fully published article here].

Subjects:

Research Funding:

This study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the Nation Institutes of Health Grants R01AR054842 and K24AR056687 to the last author (Kashikar-Zuck)

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Rheumatology
  • FIBROMYALGIA
  • ANXIETY DISORDERS
  • AFFECTIVE DISORDERS
  • JUVENILE FIBROMYALGIA
  • COMORBIDITY SURVEY REPLICATION
  • DSM-IV DISORDERS
  • ANXIETY
  • PREVALENCE
  • MOOD
  • RELIABILITY
  • DEPRESSION
  • SEVERITY
  • LIFETIME
  • CRITERIA

Psychiatric Disorders in Young Adults Diagnosed with Juvenile Fibromyalgia in Adolescence

Tools:

Journal Title:

Journal of Rheumatology

Volume:

Volume 42, Number 12

Publisher:

, Pages 2427-2433

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Objective. Adolescents with juvenile-onset fibromyalgia (JFM) have increased rates of psychiatric disorders, but to our knowledge no studies have examined psychiatric disorders in adolescents with JFM when they enter young adulthood. This study examined the prevalence of psychiatric disorders in young adults diagnosed with JFM during adolescence and the relationship between mental health diagnoses and physical functioning. Methods. Ninety-one young adults (mean age 21.60, SD 1.96) with a history of JFM being followed as part of a prospective longitudinal study and 30 matched healthy controls (mean age 21.57, SD 1.55) completed a structured interview of psychiatric diagnoses and a self-report measure of physical impairment. Results. Young adults with a history of JFM were more likely to have current and lifetime histories of anxiety disorders (70.3% and 76.9%, respectively) compared with controls (33.3% for both, both p < 0.001). Individuals with JFM were also more likely to have current and lifetime histories of major mood disorders (29.7% and 76.9%, respectively) compared with controls (10% and 40%, p < 0.05). The presence of a current major mood disorder was significantly related to impairment in physical functioning [F (1, 89) = 8.30, p < 0.01] and role limitations attributable to a physical condition [F (1, 89) = 7.09, p < 0.01]. Conclusion. Psychiatric disorders are prevalent in young adulthood for individuals with a history of JFM, and a current major mood disorder is associated with greater physical impairment. Greater attention to early identification and treatment of mood disorders in patients with JFM is warranted.

Copyright information:

© Copyright 2015 The Journal of Rheumatology. All rights reserved.

Export to EndNote